There are examples of critical molecular events for cancer development, such as TMPRSS2–ERG fusions, the most frequent molecular alteration in prostate cancer occurring in about 50% of cases, which are completely unrelated to disease outcome [46]. This evidence concerns the gene TMPRSS2 and prostate carcinoma.